Emcure Pharmaceuticals Limited — Carmustine Exporter Profile
Indian Pharmaceutical Exporter · #1 for Carmustine · $4.1M export value · DGFT Verified
Emcure Pharmaceuticals Limited is the #1 Indian exporter of Carmustine with $4.1M in export value and 81 verified shipments. Emcure Pharmaceuticals Limited holds a 18.0% market share in Carmustine exports across 19 countries. The company exports 39 pharmaceutical products worth $147.8M across 19 therapeutic categories.
Emcure Pharmaceuticals Limited — Carmustine Export Profile: Buyers & Destinations
Where Does Emcure Pharmaceuticals Limited Export Carmustine?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED KINGDOM | $650.3K | 20 | 30.3% |
| MALTA | $613.7K | 27 | 28.5% |
| SAUDI ARABIA | $161.4K | 5 | 7.5% |
| HONG KONG | $149.9K | 5 | 7.0% |
| SINGAPORE | $125.4K | 3 | 5.8% |
| LITHUANIA | $100.0K | 3 | 4.7% |
| COLOMBIA | $100.0K | 2 | 4.7% |
| CANADA | $50.0K | 1 | 2.3% |
| THAILAND | $50.0K | 1 | 2.3% |
| ITALY | $50.0K | 2 | 2.3% |
Emcure Pharmaceuticals Limited exports Carmustine to 20 countries. The largest destination is UNITED KINGDOM accounting for 30.3% of Emcure Pharmaceuticals Limited's Carmustine shipments, followed by MALTA (28.5%) and SAUDI ARABIA (7.5%). These destinations reflect Emcure Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Carmustine from Emcure Pharmaceuticals Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TILLOMED MALTA LTD | MALTA | $613.2K | 23 |
| TILLOMED LABORATORIES LTD | UNITED KINGDOM | $600.0K | 16 |
| ARABIAN HEALTH CARE SUPPLY CO | SAUDI ARABIA | $151.6K | 4 |
| HIND WING CO.LTD. | HONG KONG | $149.9K | 5 |
| JSC VILNIAUS TRANZITAS | LITHUANIA | $100.0K | 3 |
| ADVAGEN PTE LTD | SINGAPORE | $83.0K | 2 |
| MARCAN PHARMACEUTICALS INC., | CANADA | $50.0K | 1 |
| TILLOMED LABORATORIES LIMITED | UNITED KINGDOM | $50.0K | 2 |
| AL PHARMA S A S | COLOMBIA | $50.0K | 1 |
| ALLIANCE PHARMA CO LIMITED | THAILAND | $50.0K | 1 |
Emcure Pharmaceuticals Limited supplies Carmustine to 28 buyers globally. The largest buyer is TILLOMED MALTA LTD (MALTA), followed by TILLOMED LABORATORIES LTD (UNITED KINGDOM) and ARABIAN HEALTH CARE SUPPLY CO (SAUDI ARABIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Carmustine Export Value and How Much Does Emcure Pharmaceuticals Limited Contribute?
India exported $6.5M worth of Carmustine through 340 shipments from 50 suppliers to 54 countries, serving 135 buyers globally. Emcure Pharmaceuticals Limited contributes $4.1M to this total, accounting for 18.0% of India's Carmustine exports. Emcure Pharmaceuticals Limited ships Carmustine to 20 countries through 28 buyers.
What Is the Average Shipment Value for Emcure Pharmaceuticals Limited's Carmustine Exports?
Emcure Pharmaceuticals Limited's average Carmustine shipment value is $50.7K per consignment, based on 81 shipments totaling $4.1M. The largest destination is UNITED KINGDOM (30.3% of Emcure Pharmaceuticals Limited's Carmustine exports).
How Does Emcure Pharmaceuticals Limited Compare to Other Indian Carmustine Exporters?
Emcure Pharmaceuticals Limited ranks #1 among 50 Indian Carmustine exporters with a 18.0% market share. The top 3 exporters are EMCURE PHARMACEUTICALS LIMITED ($4.0M), MSN LABORATORIES PRIVATE LIMITED ($850.0K), INTAS PHARMACEUTICALS LIMITED ($778.2K). Emcure Pharmaceuticals Limited processed 81 shipments to 19 destination countries.
What Carmustine Formulations Does Emcure Pharmaceuticals Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| MEDICINES Combi Pack of Carmustinefor Injection USP 100 mg/vial (Lyophilized) & Propylene Glycol Inj: BATCH | $225.4K | 8 |
| MEDICINES Combi Pack of Carmustinefor Injection USP 100 mg/vial (Lyophilized) & Propylene Glycol Inj : BATCH | $200.9K | 10 |
| CARMUSTINE FOR INJECTION USP 100MG/VIAL | $200.0K | 4 |
| MEDICINES COMBI PACK OF CARMUSTINEFOR INJECTION USP 100 MG/VIAL (LYOPHILIZED) & DEHYDRATED ALCOHOL INJECTION | $187.0K | 5 |
| MEDICINES BICNU 100 MG-(Carmustine for I | $100.0K | 3 |
| MEDICINES Carmustine for Inj 100mg with | $100.0K | 4 |
| COMBI PACK BICNU(CARMUSTINE FOR INJ 100M | $50.0K | 1 |
| MEDICINES BICNU 100 MG -Carmustine for I | $50.0K | 2 |
| PHARMA:CARMUSTINE 100MG INJECTION WT DIL | $50.0K | 1 |
| MEDICINES CARMUBRIS 100 MG (Carmustine f | $50.0K | 2 |
Emcure Pharmaceuticals Limited exports 50 distinct Carmustine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is MEDICINES Combi Pack of Carmustinefor Injection USP 100 mg/v with 8 shipments worth $225.4K.
Regulatory Requirements: Exporting Carmustine to Key Markets
What Emcure Pharmaceuticals Limited must comply with to export Carmustine to its top destination countries
United Kingdom — MHRA
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Emcure Pharmaceuticals Limited Compare to Nearest Carmustine Exporters?
Exporters ranked immediately above and below #1 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | EMCURE PHARMACEUTICALS LIMITED ★ | $4.0M | 81 | 19 | $50.0K |
| 2 | MSN LABORATORIES PRIVATE LIMITED | $850.0K | 17 | 4 | $50.0K |
| 3 | INTAS PHARMACEUTICALS LIMITED | $778.2K | 44 | 6 | $17.7K |
Emcure Pharmaceuticals Limited ranks #1 among 50 Indian Carmustine exporters. Average shipment value of $50.0K compared to the market average of $129.7K. The closest competitors by value are MSN LABORATORIES PRIVATE LIMITED and INTAS PHARMACEUTICALS LIMITED.
Which Indian Ports Ship Carmustine Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 67 | 19.7% |
| SAHAR AIR CARGO ACC (INBOM4) | 45 | 13.2% |
| HYDERABAD AIR | 38 | 11.2% |
| HYDERABAD ACC (INHYD4) | 28 | 8.2% |
| AHEMDABAD AIR ACC (INAMD4) | 23 | 6.8% |
| Bombay Air | 18 | 5.3% |
| DELHI AIR | 15 | 4.4% |
| AHEMDABAD AIR | 11 | 3.2% |
What Other Advanced Oncology Products Does Emcure Pharmaceuticals Limited Export?
Emcure Pharmaceuticals Limited also exports these advanced oncology products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Emcure Pharmaceuticals Limited's Carmustine Exports
Emcure's extensive export operations are influenced by various geopolitical factors. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, increasing shipping costs and transit times for Indian exporters. This situation necessitates strategic adjustments in logistics and supply chain management to mitigate potential delays and cost escalations.
Conversely, the ongoing US-China trade tensions have opened opportunities for Indian pharmaceutical companies like Emcure to expand their footprint in the US market. The US's inclination to diversify its supply chain away from China presents a favorable environment for Indian exporters to increase their market share.
In the European Union, stringent regulatory changes, such as the Falsified Medicines Directive, impose additional compliance requirements on exporters. Emcure's adherence to these regulations is crucial for maintaining and expanding its presence in the EU market.
Emcure Pharmaceuticals Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Emcure's export operations. The company has consistently met the Good Manufacturing Practice (GMP) requirements set by the FDA, WHO, and EU authorities. However, the evolving regulatory landscape demands continuous investment in quality assurance and compliance mechanisms to ensure uninterrupted market access.
Recent incidents, such as the brief shutdown of the Pune plant due to a fire, highlight the importance of robust risk management and compliance strategies to maintain operational continuity and regulatory adherence. (tipranks.com)
About Emcure Pharmaceuticals Limited
Emcure Pharmaceuticals Limited exports 39 products worth $147.8M. Beyond Carmustine, top products include Dolutegravir, Mycophenolate, Tenofovir, Iron, Melphalan. View the complete Emcure Pharmaceuticals Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Carmustine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Carmustine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Emcure Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 84 individual customs records matching Emcure Pharmaceuticals Limited exporting Carmustine, covering 50 formulations to 20 countries via 28 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 54+ countries, 135+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Carmustine Export Data from Emcure Pharmaceuticals Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Emcure Pharmaceuticals Limited's Carmustine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Emcure Pharmaceuticals Limited
Full Company Profile →
39 products · $147.8M total trade · 19 categories
Carmustine Stats
Company Overview
Top Products by Emcure Pharmaceuticals Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Emcure Pharmaceuticals Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Carmustine. For current shipment-level data, contact TransData Nexus.